Immunotherapy
Entity.
- Evidence
- 586 documents · 147 separate publishers
- Standing
- A name from our starting list; its record is kept up to date automatically from coverage
- Time
- first seen 11 Mar 2026, last seen 14 Oct 2026
- Measured
- 5% of mentions say something specific about it; the rest only name it
- As of
- 15 Oct 2026
Where this comes from
- European Medical Journal · 2026-10-14 · Immunotherapy Before Liver Transplant Linked to Improved Survival (opens the source in a new tab)
- Medical Daily · 2026-10-14 · BioNTech mRNA Therapy Plus Keytruda Missed Its Tumor Progression Goal in HPV-Linked Head and Neck Cancer (opens the source in a new tab)
- BioPharma Dive · 2026-10-13 · BioNTech mRNA cancer immunotherapy misses first objective in key study (opens the source in a new tab)
- Cancer Cell · 2026-10-12 · Hitting KRAS G12D without the gut punch: Can immunotherapy make it last? (opens the source in a new tab)
- medRxiv Oncology · 2026-10-09 · Multimodal Immune Profile Score (IPS) as a Pan-Cancer Biomarker for Stratifying Outcomes of Immune Checkpoint Inhibitor Benefit in Microsatellite Stable Colorectal Can… (opens the source in a new tab)
- Inside Precision Medicine · 2026-10-08 · Combination Therapy Overcomes Key Barriers to Glioblastoma Immunotherapy (opens the source in a new tab)
- STAT News · 2026-10-07 · STAT+: Merck suffers a setback in Europe over its new Keytruda formulation (opens the source in a new tab)
- medRxiv Oncology · 2026-10-07 · Prior immune checkpoint inhibitor exposure, treatment interval, and severe hepatotoxicity with sotorasib in KRAS G12C-mutant non-small-cell lung cancer: a systematic r… (opens the source in a new tab)
- Fierce Pharma · 2026-10-07 · Halozyme stymies subcutaneous Keytruda launch in select European countries as Merck vows to fight patent claims (opens the source in a new tab)
- Endpoints News · 2026-10-07 · Dutch court blocks subcutaneous Keytruda in eight European countries (opens the source in a new tab)
- Seoul Economic Daily · 2026-10-06 · Samsung Biologics Making Ingredient for MSD's Keytruda Qlex (opens the source in a new tab)